[
    {
      "name": "BRAF V600E",
      "type": "mutation",
      "mentions": 42,
      "relations": [
            {
          "subject": "BRAF V600E",
          "predicate": "is treated by",
          "object": "encorafenib + cetuximab",
          "confidence": 0.92
            }
        ]
    },
    {
      "name": "encorafenib",
      "type": "drug",
      "mentions": 38,
      "relations": [
            {
          "subject": "encorafenib",
          "predicate": "combined with",
          "object": "cetuximab",
          "confidence": 0.95
            }
        ]
    },
    {
      "name": "cetuximab",
      "type": "drug",
      "mentions": 36,
      "relations": [
            {
          "subject": "cetuximab",
          "predicate": "targets",
          "object": "EGFR",
          "confidence": 0.89
            }
        ]
    },
    {
      "name": "colorectal cancer",
      "type": "disease",
      "mentions": 53,
      "relations": [
            {
          "subject": "colorectal cancer",
          "predicate": "has mutation",
          "object": "BRAF V600E",
          "confidence": 0.97
            }
        ]
    },
    {
      "name": "BEACON CRC",
      "type": "clinical trial",
      "mentions": 22,
      "relations": [
            {
          "subject": "BEACON CRC",
          "predicate": "evaluated",
          "object": "encorafenib + cetuximab",
          "confidence": 0.94
            }
        ]
    }
]